JP2008540657A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540657A5
JP2008540657A5 JP2008512387A JP2008512387A JP2008540657A5 JP 2008540657 A5 JP2008540657 A5 JP 2008540657A5 JP 2008512387 A JP2008512387 A JP 2008512387A JP 2008512387 A JP2008512387 A JP 2008512387A JP 2008540657 A5 JP2008540657 A5 JP 2008540657A5
Authority
JP
Japan
Prior art keywords
methyl
dioxo
carbamate
fluoro
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008512387A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540657A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/018613 external-priority patent/WO2006124710A1/en
Publication of JP2008540657A publication Critical patent/JP2008540657A/ja
Publication of JP2008540657A5 publication Critical patent/JP2008540657A5/ja
Withdrawn legal-status Critical Current

Links

JP2008512387A 2005-05-18 2006-05-15 選択的グルココルチコイド受容体リガンドとしてのd−ホモアンドロスタ−17−イル−カーバメート誘導体 Withdrawn JP2008540657A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68236405P 2005-05-18 2005-05-18
PCT/US2006/018613 WO2006124710A1 (en) 2005-05-18 2006-05-15 D-homoandrosta-17-yl-carbamate derivatives as selective glucocorticoid receptor ligands

Publications (2)

Publication Number Publication Date
JP2008540657A JP2008540657A (ja) 2008-11-20
JP2008540657A5 true JP2008540657A5 (cg-RX-API-DMAC7.html) 2009-06-25

Family

ID=37431567

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008512387A Withdrawn JP2008540657A (ja) 2005-05-18 2006-05-15 選択的グルココルチコイド受容体リガンドとしてのd−ホモアンドロスタ−17−イル−カーバメート誘導体

Country Status (8)

Country Link
US (1) US7745657B2 (cg-RX-API-DMAC7.html)
EP (1) EP1883624B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008540657A (cg-RX-API-DMAC7.html)
AT (1) ATE463479T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006247537B2 (cg-RX-API-DMAC7.html)
CA (1) CA2608414A1 (cg-RX-API-DMAC7.html)
DE (1) DE602006013448D1 (cg-RX-API-DMAC7.html)
WO (1) WO2006124710A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2473886C (en) 2002-01-22 2012-08-21 The Regents Of The University Of California Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
WO2013036678A1 (en) * 2011-09-07 2013-03-14 Satori Pharmaceuticals, Inc. Compounds useful for treating neurodegenerative disorders
SG11201703024VA (en) 2014-10-15 2017-05-30 Corcept Therapeutics Inc Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
US12616698B2 (en) 2021-05-05 2026-05-05 Corcept Therapeutics Incorporated Methods for reducing liver fat and for treating fatty liver disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598845A (en) * 1968-12-30 1971-08-10 Univ Leland Stanford Junior Intermediates in synthesis of 16-dehydroprogesterone
JPS5023965Y2 (cg-RX-API-DMAC7.html) 1971-03-09 1975-07-18
DE2349022A1 (de) * 1973-09-26 1975-04-10 Schering Ag Neue d-homo-steroide
DE2442616A1 (de) * 1974-09-04 1976-03-18 Schering Ag Neue d-homo-steroide

Similar Documents

Publication Publication Date Title
CA2512987A1 (en) 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators
AU2003270783C1 (en) Octahydro-2-H-naphtho[1,2-F] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
MX2007006109A (es) Derivados de tiazol sustituidos en 5-carboxamido que interactuan con canales de iones, en particular con canales ionicos de la familia de kv.
WO2021259224A1 (zh) 三嗪苯甲酸酯类化合物及其应用
CA2549053A1 (en) Tricyclic steroid hormone nuclear receptor modulators
EP1599201A2 (en) Selective non-steroidal glucocorticoid receptor modulators
Bansal et al. Design, synthesis and evaluation of novel 16-imidazolyl substituted steroidal derivatives possessing potent diversified pharmacological properties
JP2009510097A5 (cg-RX-API-DMAC7.html)
JP2007515431A5 (cg-RX-API-DMAC7.html)
IL193449A (en) Substituted arylsulfonamides as antiviral agents
CA2586271A1 (en) Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors
JP2012524107A5 (cg-RX-API-DMAC7.html)
CN116583184A (zh) 制备n-(1-甲基-1h-四唑-5-基)-2-(((2-甲基-2h-四唑-5-基)甲氧基)甲基)-6-(三氟甲基)烟酰胺的方法
EP2268630A2 (en) Hexahydrocyclopentylýf¨indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators
WO2009111214A1 (en) Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
WO1999033827A1 (en) Novel imidazole derivatives
WO1992019611A1 (en) Novel benzopyran derivative
US7745657B2 (en) D-homoandrosta-17-yl carbamate derivatives as selective glucocorticoid receptor ligands
CN104650036B (zh) 6‑取代苯基喹唑啉酮类化合物及其用途
RU2006143839A (ru) Кристаллические модификации
Tagmose et al. Synthesis and biological activity of 3, 3-Diamino-sulfonylacrylonitriles as novel inhibitors of glucose induced insulin secretion from beta cells
JPH08208613A (ja) 2−クロロ−6−ヒドロキシイソニコチン酸誘導体及び植物病害防除剤
PRIYA et al. Docking Studies and Antiinflammatory Activity of Novel 4 (3H)-Quinazolinone Derivatives